Cite
HARVARD Citation
Talbot, T. et al. (n.d.). 87: Resource use associated with the management of docetaxel-related haematological toxicities, including neutropenic sepsis (NS), in patients with advanced non-small cell lung cancer (NSCLC) in the UK NHS: REVEAL-NS. Lung cancer. pp. S41-. [Online].